Jones Financial Companies
GOSS icon

Jones Financial Companies’s Gossamer Bio GOSS Stock Holding History

Jones Financial Companies’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$707 Sell
56
-27
-33% -$603 ﹤0.01% 4690
2026
Q1 		$2.3K Sell
83
-164
-66% -$20.6K ﹤0.01% 4110
2025
Q4 		$61.3K Buy
247
+30
+14% +$6.85K ﹤0.01% 2431
2025
Q3 		$46.9K Buy
217
+125
+136% +$22K ﹤0.01% 2407
2025
Q2 		$9.17K Buy
+92
New +$8.03K ﹤0.01% 2903

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Jones Financial Companies's GOSS Position: Q2 2026 in Review

Jones Financial Companies reduced its Gossamer Bio (GOSS) stake by 33% in Q2 2026, selling an estimated $603 and leaving 56 shares worth $707. The position accounts for ﹤0.01% of the portfolio, ranked #4690.

Jones Financial Companies first reported a position in GOSS in Q2 2025 and has held it in 5 quarters since. The position peaked at $61.3K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Jones Financial Companies held 56 shares of Gossamer Bio worth $707 as of Q2 2026.
  • Jones Financial Companies sold 27 Gossamer Bio shares in Q2 2026, an estimated $603.
  • Gossamer Bio made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4690 holding.
  • Jones Financial Companies first reported a position in Gossamer Bio in Q2 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Gossamer Bio position peaked at $61.3K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.